CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
chlorothiazidedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00004360
NCT00004360N/ACompleted
CompareCT.gov

Study of Genotype and Phenotype Expression in Congenital Nephrogenic Diabetes Insipidus

National Center for Research Resources (NCRR)·observational·Posted Oct 19, 1999·Updated Jun 24, 2005

In Brief

An observational study evaluating chlorothiazide for Diabetes Insipidus, Nephrogenic. Completed.

Detailed Summary

OBJECTIVES: I. Determine the relationship between genotype variations and clinical phenotype in patients with congenital nephrogenic diabetes insipidus.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Insipidus, Nephrogenic
Countries--
CollaboratorsNorthwestern University

Timeline

N/ACompletedFinished
199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 19, 1999
Enrollment StartSep 1, 1995
TodayJul 2, 2026
Posted 26.7 years ago

Interventions

chlorothiazidedrug